Ignite Creation Date:
2024-05-06 @ 12:45 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03836209
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-22
First Post:
2019-02-07
Brief Title:
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Sponsor:
PrECOG LLC
Organization:
PrECOG LLC
Organization Data
Organization:
PrECOG LLC
Class:
OTHER
Study ID:
PrE0905
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PrECOG LLC
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Astellas Pharma Inc | INDUSTRY |